The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Emerging insights into Transforming growth factor Smad signal in hepatic fibrogenesis
Open accessAbstract
rrespective of initial stimuli, increased production of type I collagen is a common hallmark of fibrotic diseases in various organs including the liver.A dynamic balance between the production and degradation of collagen is seen, which is rigorously controlled by several growth factors and cytokines.Of these, transforming growth factor b (TGFb) is the most potent factor in stimulating type I collagen gene transcription.It also regulates expression of matrix metalloproteinases and their inhibitors, and modulates inflammatory reactions by influencing T cell functions.Therefore, TGFb is considered to be the major factor accelerating liver fibrosis.Identification and characterisation of Smad proteins, intracellular mediators of the signal transduction of TGFb, have led to a better understanding of the precise mechanisms of TGFb functions from the viewpoint of its intracellular signalling pathway and crosstalk with other factors.Several studies have focused on the suppression of TGFb activation and intervention of the TGFb/Smad signalling pathways to treat liver fibrosis.However, as generalised blockade of TGFb activity may result in the promotion of carcinogenesis and excessive immune reactions, much attention has to be paid to selective intervention of the TGFb/ Smad signal specifically in collagen-producing cells in the fibrotic tissue.TGFb also affects the growth and differentiation of stem and progenitor cells.From this point of view, a new concept of the treatment for liver fibrosis may arise from the discipline of stem cell biology by modulating TGFb and Smad signalling in stem/progenitor cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Massagué, J., Seoane, J., & Wotton, D. (2005) · Genes & Development · doi:10.1101/gad.1350705 · Cited by 2,452
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809
Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,634
Zeisberg, M., Hanai, J.-I., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., & Kalluri, R. (2003) · Nature Medicine · doi:10.1038/nm888 · Cited by 1,346
A mechanism of repression of TGFbeta / Smad signaling by oncogenic Ras
Kretzschmar, M., Doody, J., Timokhina, I., & Massague, J. (1999) · Genes & Development · doi:10.1101/gad.13.7.804 · Cited by 1,004
Yang, X. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1280 · Cited by 889
Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1
Kretzschmar, M., Doody, J., & Massagu, J. (1997) · Nature · doi:10.1038/39348 · Cited by 877
Ebisawa, T., Fukuchi, M., Murakami, G., Chiba, T., Tanaka, K., Imamura, T., & Miyazono, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100008200 · Cited by 844
Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway
Ulloa, L., Doody, J., & Massagué, J. (1999) · Nature · doi:10.1038/17826 · Cited by 812
Gressner, A. M., & Weiskirchen, R. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00292.x · Cited by 718
Smad2 role in mesoderm formation, left–right patterning and craniofacial development
Nomura, M., & Li, E. (1998) · Nature · doi:10.1038/31693 · Cited by 599
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
Ueki, T., Kaneda, Y., Tsutsui, H., Nakanishi, K., Sawa, Y., Morishita, R., Matsumoto, K., Nakamura, T., Takahashi, H., Okamoto, E., et al. (1999) · Nature Medicine · doi:10.1038/5593 · Cited by 587
Interdependent SMAD and JNK Signaling in Transforming Growth Factor-β-mediated Transcription
Engel, M. E., McDonnell, M. A., Law, B. K., & Moses, H. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37413 · Cited by 531
Transplantation of Bone Marrow Cells Reduces Ccl4–Induced Liver Fibrosis in Mice
Sakaida, I., Terai, S., Yamamoto, N., Aoyama, K., Ishikawa, T., Nishina, H., & Okita, K. (2004) · Hepatology · doi:10.1002/hep.20452 · Cited by 524
The role of epithelial-to-mesenchymal transition in renal fibrosis
Zeisberg, M., & Kalluri, R. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0517-9 · Cited by 507
The Bone Marrow Functionally Contributes to Liver Fibrosis
Russo, F. P., Alison, M. R., Bigger, B. W., Amofah, E., Florou, A., Amin, F., Bou–Gharios, G., Jeffery, R., Iredale, J. P., & Forbes, S. J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.036 · Cited by 483
A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · PubMed · Cited by 461
Roberts, A. B., Lamb, L. C., Newton, D. L., Sporn, M. B., De Larco, J. E., & Todaro, G. J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.6.3494 · Cited by 448
Hanafusa, H., Ninomiya-Tsuji, J., Masuyama, N., Nishita, M., Fujisawa, J.-I., Shibuya, H., Matsumoto, K., & Nishida, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27161 · Cited by 442
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis☆
Forbes, S. J., Russo, F. P., Rey, V., Burra, P., Rugge, M., Wright, N. A., & Alison, M. R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.025 · Cited by 436
A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · Genes & Development · doi:10.1101/gad.14.2.187 · Cited by 421
Piek, E., Ju, W. J., Heyer, J., Escalante-Alcalde, D., Stewart, C. L., Weinstein, M., Deng, C., Kucherlapati, R., Böttinger, E. P., & Roberts, A. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102382200 · Cited by 397
Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats
Dooley, S., Hamzavi, J., Breitkopf, K., Wiercinska, E., Said, H. M., Lorenzen, J., Ten Dijke, P., & Gressner, A. M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00666-8 · Cited by 369
Transforming growth factor β and the liver
Bissell, M. D., Roulot, D., & George, J. (2001) · Hepatology · doi:10.1053/jhep.2001.28457 · Cited by 348
George, J., Roulot, D., Koteliansky, V. E., & Bissell, D. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12719 · Cited by 322
Inagaki, Y., Truter, S., & Ramirez, F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36699-1 · Cited by 307
Self-citationKnittel, T., Kobold, D., Saile, B., Grundmann, A., Neubauer, K., Piscaglia, F., & Ramadori, G. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70407-5 · Cited by 306
Baroni, G. S., D’Ambrosio, L., Curto, P., Casini, A., Mancini, R., Jezequel, A. M., & Benedetti, A. (1996) · Hepatology · doi:10.1002/hep.510230538 · Cited by 295
Qi, Z., Atsuchi, N., Ooshima, A., Takeshita, A., & Ueno, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2345 · Cited by 288
P38 Mapk Mediates Fibrogenic Signal Through Smad3 Phosphorylation in Rat Myofibroblasts
Furukawa, F., Matsuzaki, K., Mori, S., Tahashi, Y., Yoshida, K., Sugano, Y., Yamagata, H., Matsushita, M., Seki, T., Inagaki, Y., et al. (2003) · Hepatology · doi:10.1002/hep.1840380414 · Cited by 265
Self-citationThe Role of Smad3 in Mediating Mouse Hepatic Stellate Cell Activation
Schnabl, B., Kweon, Y. O., Frederick, J. P., Wang, X.-F., Rippe, R. A., & Brenner, D. A. (2001) · Hepatology · doi:10.1053/jhep.2001.25349 · Cited by 258
Sobesky, R., Mathurin, P., Charlotte, F., Moussalli, J., Olivi, M., Vidaud, M., Ratziu, V., Opolon, P., & Poynard, T. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70135-6 · Cited by 252
Magness, S. T., Bataller, R., Yang, L., & Brenner, D. A. (2004) · Hepatology · doi:10.1002/hep.20427 · Cited by 246
Nakamura, T., Sakata, R., Ueno, T., Sata, M., & Ueno, H. (2000) · Hepatology · doi:10.1053/jhep.2000.9109 · Cited by 242
García-Trevijano, E. R., Iraburu, M. J., Fontana, L., Domínguez-Rosales, J. A., Auster, A., Covarrubias-Pinedo, A., & Rojkind, M. (1999) · Hepatology · doi:10.1002/hep.510290346 · Cited by 236
Ghosh, A. K., Yuan, W., Mori, Y., & Varga, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203693 · Cited by 231
Ghosh, A. K., Yuan, W., Mori, Y., Chen, S.-J., & Varga, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004709200 · Cited by 225
Zhang, W., Ou, J., Inagaki, Y., Greenwel, P., & Ramirez, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003339200 · Cited by 214
Self-citationγ–Interferon Treatment Inhibits Collagen Deposition in Murine Schistosomiasis
Czaja, M. J., Weiner, F. R., Takahashi, S., Giambrone, M.-A., Der Van Meide, P. H., Schellekens, H., Biempica, L., & Zern, M. A. (1989) · Hepatology · doi:10.1002/hep.1840100508 · Cited by 189
Transforming Growth Factor-β Signaling in Stem Cells and Cancer
Mishra, L., Derynck, R., & Mishra, B. (2005) · Science · doi:10.1126/science.1118389 · Cited by 188
Liu, C., Gaça, M. D. A., Swenson, E. S., Vellucci, V. F., Reiss, M., & Wells, R. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207728200 · Cited by 186
TGF-β1 activates MAP kinase in human mesangial cells: A possible role in collagen expression
Hayashida, T., Poncelet, A.-C., Hubchak, S. C., & Schnaper, H. W. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00733.x · Cited by 185
Interferon alfa and gamma inhibit proliferation and collagen synthesis of human ito cells in culture
Mallat, A., Preaux, A.-M., Blazejewski, S., Rosenbaum, J., Dhumeaux, D., & Mavier, P. (1995) · Hepatology · doi:10.1002/hep.1840210418 · Cited by 180
Inhibition of Rat Hepatic Lipocyte Activation in Culture by Interferon–γ
Rockey, D. C., Maher, J. J., Jarnagin, W. R., Gabbiani, G., & Friedman, S. L. (1992) · Hepatology · doi:10.1002/hep.1840160325 · Cited by 179
BMP7 antagonizes TGF-β-dependent fibrogenesis in mesangial cells
Wang, S., & Hirschberg, R. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00382.2002 · Cited by 177
Tahashi, Y., Matsuzaki, K., Date, M., Yoshida, K., Furukawa, F., Sugano, Y., Matsushita, M., Himeno, Y., Inagaki, Y., & Inoue, K. (2002) · Hepatology · doi:10.1053/jhep.2002.30083 · Cited by 176
Self-citationTerai, S. (2003) · Journal of Biochemistry · doi:10.1093/jb/mvg173 · Cited by 175
Greenwel, P., Tanaka, S., Penkov, D., Zhang, W., Olive, M., Moll, J., Vinson, C., Di Liberto, M., & Ramirez, F. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.912-918.2000 · Cited by 175
Matsuda, Y., Matsumoto, K., Nakamura, T., & Ichida, T. (1995) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a124958 · Cited by 175
Sp1 Is Required for the Early Response of α2(I) Collagen to Transforming Growth Factor-β1
Greenwel, P., Inagaki, Y., Hu, W., Walsh, M., & Ramirez, F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.19738 · Cited by 171
Self-citationTsukada, S., Westwick, J. K., Ikejima, K., Sato, N., & Rippe, R. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409381200 · Cited by 170
Verrecchia, F., Pessah, M., Atfi, A., & Mauviel, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005310200 · Cited by 170
Yoshida, K., Matsuzaki, K., Mori, S., Tahashi, Y., Yamagata, H., Furukawa, F., Seki, T., Nishizawa, M., Fujisawa, J., & Okazaki, K. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62324-3 · Cited by 165
Oval cell‐mediated liver regeneration: Role of cytokines and growth factors
LOWES, K. N., CROAGER, E. J., OLYNYK, J. K., ABRAHAM, L. J., & YEOH, G. C. T. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.02906.x · Cited by 163
Antifibrogenic Effect of A Deletion Variant of Hepatocyte Growth Factor on Liver Fibrosis in Rats
Yasuda, H., Imai, E., Shiota, A., Fujise, N., Morinaga, T., & Higashio, K. (1996) · Hepatology · doi:10.1002/hep.510240328 · Cited by 162
Higashi, K., Inagaki, Y., Fujimori, K., Nakao, A., Kaneko, H., & Nakatsuka, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302339200 · Cited by 158
Self-citationInagaki, Y., Nemoto, T., Kushida, M., Sheng, Y., Higashi, K., Ikeda, K., Kawada, N., Shirasaki, F., Takehara, K., Sugiyama, K., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50408 · Cited by 156
Self-citationFriedman, S. L., Yamasaki, G., & Wong, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34095-4 · Cited by 151
Kim, W., Matsumoto, K., Bessho, K., & Nakamura, T. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62323-1 · Cited by 151
Uemura, M., Swenson, E. S., Gaça, M. D. A., Giordano, F. J., Reiß, M., & Wells, R. G. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-02-0149 · Cited by 150
Beljaars, L., Molema, G., Weert, B., Bonnema, H., Olinga, P., Groothuis, G. M. M., Meijer, D. K. F., & Poelstra, K. (1999) · Hepatology · doi:10.1002/hep.510290526 · Cited by 146
Manabe, N., Chevallier, M., Chossegros, P., et al. (1993) · PubMed · Cited by 143
Okuno, M., Akita, K., Moriwaki, H., Kawada, N., Ikeda, K., Kaneda, K., Suzuki, Y., & Kojima, S. (2001) · Gastroenterology · doi:10.1053/gast.2001.24832 · Cited by 141
Ueno, H., Sakamoto, T., Nakamura, T., Qi, Z., Astuchi, N., Takeshita, A., Shimizu, K., & Ohashi, H. (2000) · Human Gene Therapy · doi:10.1089/10430340050016139 · Cited by 135
Antifibrotic therapy in chronic liver disease
Rockey, D. C. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00445-8 · Cited by 120
BMP-7 opposes TGF-β1-mediated collagen induction in mouse pulmonary myofibroblasts through Id2
Izumi, N., Mizuguchi, S., Inagaki, Y., Saika, S., Kawada, N., Nakajima, Y., Inoue, K., Suehiro, S., Friedman, S. L., & Ikeda, K. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00171.2005 · Cited by 116
Self-citationInagaki, Y., Mamura, M., Kanamaru, Y., Greenwel, P., Nemoto, T., Takehara, K., ten Dijke, P., & Nakao, A. (2001) · Journal of Cellular Physiology · doi:10.1002/1097-4652(2001)9999:9999<00::aid-jcp1059>3.0.co;2-s · Cited by 115
Self-citationAutocrine release of TGF‐β by portal fibroblasts regulates cell growth
Wells, R. G., Kruglov, E. A., & Dranoff, J. A. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00037-7 · Cited by 114
Inagaki, Y., Truter, S. L., Tanaka, S., Liberto, M. D., & Ramirez, F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3353 · Cited by 112
Self-citationBeljaars, L., Weert, B., Geerts, A. E., Meijer, D. K. F., & Poelstra, K. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00445-3 · Cited by 103
A blocking peptide for transforming growth factor-β1 activation prevents hepatic fibrosis in vivo
Kondou, H., Mushiake, S., Etani, Y., Miyoshi, Y., Michigami, T., & Ozono, K. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00377-5 · Cited by 99
Y-box Protein-1 Is the Crucial Mediator of Antifibrotic Interferon-γ Effects
Dooley, S., Said, H. M., Gressner, A. M., Floege, J., En‐Nia, A., & Mertens, P. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510215200 · Cited by 95
Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice
Cho, K., Lim, G.-W., Joo, S.-Y., Woo, S., Seoh, J., Cho, S. J., Han, H., & Ryu, K. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02364.x · Cited by 88
Inagaki, Y., Kushida, M., Higashi, K., Itoh, J., Higashiyama, R., Hong, Y. Y., Kawada, N., Namikawa, K., Kiyama, H., Bou–Gharios, G., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.088 · Cited by 87
Self-citationInagaki, Y., Nemoto, T., Nakao, A., ten Dijke, P., KOBAYASHI, K. P., Takehara, K., & Greenwel, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010485200 · Cited by 78
Self-citationOzaki, I., Zhao, G., Mizuta, T., Ogawa, Y., Hara, T., Kajihara, S., Hisatomi, A., Sakai, T., & Yamamoto, K. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00245-8 · Cited by 78
Breitkopf, K., Sawitza, I., Westhoff, J. H., Wickert, L., Dooley, S., & Gressner, A. M. (2005) · Gut · doi:10.1136/gut.2004.042911 · Cited by 77
Higashi, K., Inagaki, Y., Suzuki, N., Mitsui, S., Mauviel, A., Kaneko, H., & Nakatsuka, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208724200 · Cited by 74
Self-citationInagaki, Y., Truter, S. L., Greenwel, P., Rojkind, M., Unoura, M., KOBAYASHI, K. P., & Ramirez, F. (1995) · Hepatology · doi:10.1002/hep.1840220230 · Cited by 63
Self-citationRodríguez‐Barbero, A., Obreo, J., Yuste, L., Montero, J. C., Rodríguez-Peña, A. B., Pandiella, A., Bernabéu, C., & López-Novoa, J. M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02337-2 · Cited by 61
Reunanen, N., Foschi, M., Han, J., & Kähäri, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000175200 · Cited by 60
Schaefer, B., Rivas, A., Meraz‐Cruz, N., Reyes-Romero, M. A., Nazará, Z., Domínguez-Rosales, J. A., Schuppan, D., Greenwel, P., & Rojkind, M. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64312-x · Cited by 59
Identification of Endoglin in Rat Hepatic Stellate Cells
Meurer, S. K., Tihaa, L., Lahme, B., Gressner, A. M., & Weiskirchen, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405411200 · Cited by 57
Lechuga, C. G., Nazará, Z., Rosales, J.-A. D., Morris, E. R., Rincón‐Sánchez, A. R., Rivas, A., Esteban-Gamboa, A., & Rojkind, M. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00264.2003 · Cited by 54
Abécassis, L., Rogier, E., Vázquez, A., Atfi, A., & Bourgeade, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403294200 · Cited by 45
Activation of Proα2(I) Collagen Promoter during Hepatic Fibrogenesis in Transgenic Mice
Inagaki, Y., Truter, S. L., Bou–Gharios, G., Garrett‐Sinha, L. A., Crombrugghe, B. D., Nemoto, T., & Greenwel, P. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9345 · Cited by 33
Self-citationWang, Z., Wang, M., & Carr, B. I. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200006)183:3<381::aid-jcp11>3.0.co;2-o · Cited by 27
Extracellular matrix and the liver : approach to gene therapy
Okazaki, I. (2003) · Medical Entomology and Zoology · Cited by 15
Self-citationJanoschek, N., de Leur, E. V., Gressner, A. M., & Weiskirchen, R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.147 · Cited by 14
Cited by
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Pathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
Mechanisms of hepatic fibrogenesis
Lee, U. E., & Friedman, S. L. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.005 · Cited by 923
Metadata
- Authors
- Inagaki, Y., & Okazaki, I.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2007-02-01
- Volume
- 56
- Issue
- 2
- Pages
- 284-292
- ISSN
- 0017-5749 (ISSN-L)
- OpenAlex
- W2017961355
- Cited by
- 464
- References
- 89
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.